Skip to main content
Erschienen in: Supportive Care in Cancer 5/2010

01.05.2010 | Original Article

Development of the MASCC teaching tool for patients receiving oral agents for cancer

verfasst von: Sultan Kav, Lisa Schulmeister, Anita Nirenberg, Linda Barber, Judi Johnson, Cynthia Rittenberg

Erschienen in: Supportive Care in Cancer | Ausgabe 5/2010

Einloggen, um Zugang zu erhalten

Abstract

Background

Oral agents for cancer treatment commonly are prescribed throughout the world. Since oral agents usually are self-administered or administered by lay caregivers, patient education is vital to help ensure that the oral agents are being stored, handled, and taken correctly. When oral agents are taken as prescribed and patients are well informed about signs and symptoms to report, patient outcomes are optimized. Patient education varies globally; consequently, there is a need for a consistent and comprehensive approach to educate patients about oral cancer treatment.

Goal of work

To create a teaching tool to be used with patients receiving oral cancer agents for worldwide use.

Materials and methods

Six oncology nurse experts conducted a literature review and convened as an expert panel to draft a teaching tool for patients receiving oral cancer agents. The tool includes key assessment questions, generic education discussion points, drug-specific education, and evaluation questions to help ensure that patients/caregivers understand the information provided. Eighteen healthcare providers from 15 countries reviewed the tool for clarity and usefulness in practice by scoring each item in the teaching tool on a 0–10 scale (“0 = not at all to “10” = most clear/useful”). Items that scored 5 or below required comments. At the Multinational Association for Supportive Care in Cancer (MASCC) Symposium in 2008, the healthcare providers who reviewed the teaching tool met with the oncology nurse experts who had developed the tool to review the item scores and revise the tool as necessary.

Results

All items on the teaching tool received high scores, with the exception of items on refilling prescriptions and insurance issues, which vary from country to country. There was consensus that the MASCC Teaching Tool for Patients Receiving Oral Agents for Cancer was ready to be used and further evaluated in clinical practice.

Conclusions

The MASCC Teaching Tool for Patients Receiving Oral Agents for Cancer is an available resource to assist healthcare providers assess and teach patients about oral cancer treatment.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Bartel S (2007) Safe practices and financial considerations in using oral chemotherapy agents. Am J Health Syst Pharm 64(9 Suppl 5):S8–S14CrossRefPubMed Bartel S (2007) Safe practices and financial considerations in using oral chemotherapy agents. Am J Health Syst Pharm 64(9 Suppl 5):S8–S14CrossRefPubMed
2.
Zurück zum Zitat Findlay M, von Minckwitz G, Wardley A (2008) Effective oral chemotherapy for breast cancer: pillars of strength. Ann Oncol 19(2):212–222CrossRefPubMed Findlay M, von Minckwitz G, Wardley A (2008) Effective oral chemotherapy for breast cancer: pillars of strength. Ann Oncol 19(2):212–222CrossRefPubMed
3.
Zurück zum Zitat Hartigan K (2003) Patient education: the cornerstone of successful oral chemotherapy treatment. Clin J Oncol Nurs 7(6):21–24CrossRefPubMed Hartigan K (2003) Patient education: the cornerstone of successful oral chemotherapy treatment. Clin J Oncol Nurs 7(6):21–24CrossRefPubMed
4.
Zurück zum Zitat Hilton A, Skrutkowski M (2002) Translating instruments into other languages: development and testing processes. Cancer Nurs 25(1):1–7CrossRefPubMed Hilton A, Skrutkowski M (2002) Translating instruments into other languages: development and testing processes. Cancer Nurs 25(1):1–7CrossRefPubMed
5.
Zurück zum Zitat Jones P, Lee J, Phiollips L, Zhang X, Jaceldo KJ (2001) An adaptation of Brislin’s Translation Model for cross-cultural research. Nurs Res 50(5):300–304CrossRefPubMed Jones P, Lee J, Phiollips L, Zhang X, Jaceldo KJ (2001) An adaptation of Brislin’s Translation Model for cross-cultural research. Nurs Res 50(5):300–304CrossRefPubMed
6.
Zurück zum Zitat Kav S, Bostanci H (2006) Role of the nurse in patient education and follow-up of people receiving oral chemotherapy treatment in Turkey. Support Care Cancer 14(12):1252–1257CrossRefPubMed Kav S, Bostanci H (2006) Role of the nurse in patient education and follow-up of people receiving oral chemotherapy treatment in Turkey. Support Care Cancer 14(12):1252–1257CrossRefPubMed
7.
Zurück zum Zitat Kav S, Johnson J, Rittenberg C, Fernadez-Ortega P, Suominen T, Olsen PR, Patiraki E, Porock D, Dahler A, Toliusiene J, Tadic D, Pittayapan P, Roy V, Wang Q, Colak M, Saca-Hazboun H, Makumi D, Kadmon I, Ami SB, Anderson E, Clark-Snow R (2008) Role of the nurse in patient education and follow-up of people receiving oral chemotherapy treatment: an International survey. Support Care Cancer 16:1075–1083CrossRefPubMed Kav S, Johnson J, Rittenberg C, Fernadez-Ortega P, Suominen T, Olsen PR, Patiraki E, Porock D, Dahler A, Toliusiene J, Tadic D, Pittayapan P, Roy V, Wang Q, Colak M, Saca-Hazboun H, Makumi D, Kadmon I, Ami SB, Anderson E, Clark-Snow R (2008) Role of the nurse in patient education and follow-up of people receiving oral chemotherapy treatment: an International survey. Support Care Cancer 16:1075–1083CrossRefPubMed
8.
Zurück zum Zitat Moore S (2007) Facilitating oral chemotherapy treatment and compliance through patient/family-focused education. Cancer Nurs 30(2):112–122CrossRefPubMed Moore S (2007) Facilitating oral chemotherapy treatment and compliance through patient/family-focused education. Cancer Nurs 30(2):112–122CrossRefPubMed
9.
Zurück zum Zitat Ruddy K, Mayer E, Partridge A (2009) Patient adherence and persistence with oral anticancer treatment. CA Cancer J Clin 59(1):56–66CrossRefPubMed Ruddy K, Mayer E, Partridge A (2009) Patient adherence and persistence with oral anticancer treatment. CA Cancer J Clin 59(1):56–66CrossRefPubMed
10.
Zurück zum Zitat Viele CS (2007) Managing oral chemotherapy: the healthcare practitioner’s role. Am J Health Syst Pharm 64(9 Suppl 5):S25–S32CrossRefPubMed Viele CS (2007) Managing oral chemotherapy: the healthcare practitioner’s role. Am J Health Syst Pharm 64(9 Suppl 5):S25–S32CrossRefPubMed
11.
Zurück zum Zitat Wyatt K, Carter M, Mahtani V, Barnard A, Hawton A, Britten N (2008) The impact of consumer involvement in research: an evaluation of consumer involvement in the London Primary Care Studies Programme. Fam Pract 25:154–161CrossRefPubMed Wyatt K, Carter M, Mahtani V, Barnard A, Hawton A, Britten N (2008) The impact of consumer involvement in research: an evaluation of consumer involvement in the London Primary Care Studies Programme. Fam Pract 25:154–161CrossRefPubMed
Metadaten
Titel
Development of the MASCC teaching tool for patients receiving oral agents for cancer
verfasst von
Sultan Kav
Lisa Schulmeister
Anita Nirenberg
Linda Barber
Judi Johnson
Cynthia Rittenberg
Publikationsdatum
01.05.2010
Verlag
Springer-Verlag
Erschienen in
Supportive Care in Cancer / Ausgabe 5/2010
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-009-0692-5

Weitere Artikel der Ausgabe 5/2010

Supportive Care in Cancer 5/2010 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.